VALOR-HCM: Treatment with mavacamten decreased need for septal reduction therapy in patients with hypertrophic cardiomyopathy.
Key Points: In the VALOR-HCM study, patients with severely symptomatic obstructive HCM…
Tag: ACC 2022
Key Points: In the VALOR-HCM study, patients with severely symptomatic obstructive HCM…